Capricor Therapeutics | CAPR - Net Income

Stock Price
34.68
Daily Change
0.14 0.41%
Monthly
13.48%
Yearly
253.16%
Q2 Forecast
30.35

Capricor Therapeutics reported $-30.17M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Alterity Therapeutics Limited AUD -6.3M 525.41K Dec/2025
Bioline Rx USD -977K 2.96M Sep/2025
Capricor Therapeutics USD -30.17M 5.6M Dec/2025
Cipla INR 6.76B 6.75B Dec/2025
Cytokinetics USD -183.03M 123.15M Dec/2025
Geron USD -31.14M 12.72M Dec/2025
Grifols EUR 114.37M 34.03M Dec/2025
Immunic USD -24.37M 2.99M Sep/2024
J&J USD 5.12B 36M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Prothena USD -21.59M 14.95M Dec/2025
PTC Therapeutics USD -134.96M 150.86M Dec/2025
Sarepta Therapeutics USD -412.23M 232.28M Dec/2025